Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7126030
Reference Type
Journal Article
Title
The application of machine learning techniques to innovative antibacterial discovery and development
Author(s)
Serafim, MSaM; Kronenberger, T; Oliveira, PR; Poso, A; Honorio, KM; Mota, BEF; Maltarollo, VG; ,
Year
2020
Is Peer Reviewed?
Yes
Journal
Expert Opinion on Drug Discovery
ISSN:
1746-0441
Publisher
TAYLOR & FRANCIS LTD
Location
ABINGDON
Page Numbers
1165-1179
PMID
32552005
DOI
10.1080/17460441.2020.1776696
Web of Science Id
WOS:000545725900001
Abstract
Introduction After the initial wave of antibiotic discovery, few novel classes of antibiotics have emerged, with the latest dating back to the 1980's. Furthermore, the pace of antibiotic drug discovery is unable to keep up with the increasing prevalence of antibiotic drug resistance. However, the increasing amount of available data promotes the use of machine learning techniques (MLT) in drug discovery projects (e.g. construction of regression/classification models and ranking/virtual screening of compounds). Areas covered In this review, the authors cover some of the applications of MLT in medicinal chemistry, focusing on the development of new antibiotics, the prediction of resistance and its mechanisms. The aim of this review is to illustrate the main advantages and disadvantages and the major trends from studies over the past 5 years. Expert opinion The application of MLT to antibacterial drug discovery can aid the selection of new and potent lead compounds, with desirable pharmacokinetic and toxic profiles for further optimization. The increasing volume of available data along with the constant improvement in computational power and algorithms has meant that we are experiencing a transition in the way we face modern issues such as drug resistance, where our decisions are data-driven and experiments can be focused by data-suggested hypotheses.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity